Further to its letter dated February 13, 2023, Postal Ballot Notice (‘Notice’) pursuant to the provisions of Section 110 of the Companies Act, 2013, read with related Rules, as amended from time to time, seeking approval of the Members of the company was conducted by way of remote e-voting process for the Special Resolution as set out in the Notice. Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), Krebs Biochemicals and Industries has informed that it enclosed the details of the voting results (Annexure A) and the Report of the Scrutinizer (Annexure B). Based on the report of the scrutinizer, it has informed that the Members of the Company have duly passed the above Special Resolution with requisite majority. The voting results and the Report of the Scrutinizer shall be uploaded on the Company’s website www.krebsbiochem.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: